Ekso Bionics Holdings, Inc. (EKSO)
| Market Cap | 35.59M |
| Revenue (ttm) | 16.98M |
| Net Income (ttm) | -15.16M |
| Shares Out | 14.23M |
| EPS (ttm) | -1.12 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 790,620 |
| Open | 1.88 |
| Previous Close | 1.88 |
| Day's Range | 1.88 - 2.70 |
| 52-Week Range | 0.62 - 2.70 |
| Beta | 1.88 |
| Analysts | Strong Buy |
| Price Target | 9.00 (+260.0%) |
| Earnings Date | Oct 26, 2023 |
About EKSO
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company also provide... [Read more]
Financial Performance
In 2022, EKSO's revenue was $12.91 million, an increase of 14.81% compared to the previous year's $11.25 million. Losses were -$15.08 million, 54.4% more than in 2021.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for EKSO stock is "Strong Buy" and the 12-month stock price forecast is $9.0.
News
Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29
SAN RAFAEL, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ann...
Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal
Ruling Could Significantly Expand Use of Ekso Indego Personal in Home and Community Markets SAN RAFAEL, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Compa...
Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%
SAN RAFAEL, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today rep...
Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023
SAN RAFAEL, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today ann...
Ekso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
SAN RAFAEL, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today an...
Ekso Bionics to Report Second Quarter 2023 Financial Results on July 27, 2023
SAN RAFAEL, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industr...
Ekso Bionics Announces 61% Increase in First Quarter 2023 Revenues
Highest Quarterly Revenues in Company History SAN RAFAEL, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in...
Ekso Bionics to Report First Quarter 2023 Financial Results on April 27, 2023
SAN RAFAEL, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today an...
Ekso Bionics Announces Ekso Indego Therapy Order by SoldierStrong
- SoldierStrong to Donate Device to the Charlie Norwood Department of Veteran Affairs Medical Center in Augusta, GA - SAN RAFAEL, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics (Nasdaq: EKSO)...
Ekso Bionics Reports Fourth Quarter and Year End 2022 Results
SAN RAFAEL, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today re...
Ekso Bionics to Showcase Integrated Functional Electrical Stimulation for Indego Therapy at APTA Meeting
SAN RAFAEL, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Ekso Bionics (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced it will ...
Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego® Product Line From Parker Hannifin Corporation
Broadens Ekso Bionics' product portfolio into home use
Ekso Bionics Reports Third Quarter 2022 Results
Quarterly Record of 33 EksoNR Bookings in Q3 2022
Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment Conference
SAN RAFAEL, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today an...
Ekso Bionics Reports Second Quarter 2022 Results
RICHMOND, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today repor...
Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28
RICHMOND, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today annou...
Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Multiple Sclerosis Patients
First FDA Cleared Exoskeleton for Rehabilitation Use in Patients with Multiple Sclerosis
Ekso Bionics Appoints Jerome Wong Interim Chief Financial Officer
RICHMOND, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announ...
Ekso Bionics Reports First Quarter 2022 Results
RICHMOND, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today repo...
Ekso Bionics to Report First Quarter 2022 Financial Results on April 28
RICHMOND, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today anno...
Ekso Bionics to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022
RICHMOND, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today annou...
Ekso Bionics Announces Leadership Transition
Board Member Steven Sherman to be Appointed CEO
Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results
Company Achieves Record Quarterly Revenue of $3.9 million to $4.1 million 1
Ekso Bionics to Participate at the H.C. Wainwright BioConnect Virtual Conference
RICHMOND, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that manage...
Ekso Bionics Appoints Corinna E. Lathan, Ph.D.
RICHMOND, Calif., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today annou...